Movement Disorders (revue) - Checkpoint (PascalFrancis)

Index « FC03.fr.i » - entrée « Apomorphine »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Apolipoprotéine E < Apomorphine < Apoptose  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 55.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000710 (2011) Jeban Ganesalingam [Royaume-Uni] ; Peter Bain [Royaume-Uni]Apomorphine-Induced Necrotic Ulcers
000711 (2011) Estelle Dellapina [France] ; Angélique Gerdelat-Mas [France] ; Fabienne Ory-Magne [France] ; Laure Pourcel [France] ; Monique Galitzky [France] ; Fabienne Calvas [France] ; Marion Simonetta-Moreau [France] ; Claire Thalamas [France] ; Pierre Payoux [France] ; Christine Brefel-Courbon [France]Apomorphine Effect on Pain Threshold in Parkinson's Disease: A Clinical and Positron Emission Tomography Study
000928 (2010) Olivier Rascol [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France] ; Anne-Marie Bonnet [France] ; Christine Brefel-Courbon [France] ; Pierre Cesaro [France] ; Philippe Damier [France] ; Bérengère Debilly [France] ; Frank Durif [France] ; Monique Galitzky [France] ; Jean-Marie Grouin [France] ; Sylvie Pennaforte [France] ; Gabriel Villafane [France] ; Sadek Yaici [France] ; Yves Agid [France]Orodispersible Sublingual Piribedil to Abort OFF Episodes: A Single Dose Placebo-Controlled, Randomized, Double-Blind, Cross-Over Study
000C13 (2010) Santiago Perez-Lloret [France] ; Emmanuelle Bondon-Guitton [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]Adverse Drug Reactions to Dopamine Agonists: A Comparative Study in the French Pharmacovigilance Database
000C68 (2009) Leon Poltawski [Royaume-Uni] ; Hazel Edwards [Royaume-Uni] ; Amy Todd [Royaume-Uni] ; Tim Watson [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Cherry Ann James [Royaume-Uni]Ultrasound Treatment of Cutaneous Side-Effects of Infused Apomorphine : A Randomized Controlled Pilot Study
000C86 (2009) Julia Vaamonde [Espagne] ; José M. Flores [Espagne] ; Roberto Weisser [Espagne] ; Ramon Ibanez [Espagne] ; José A. Obeso [Espagne]The Duration of the Motor Response to Apomorphine Boluses Is Conditioned by the Length of a Prior Infusion in Parkinson's Disease
001273 (2008) Pedro J. Garcia Ruiz ; Angel Sesar Ignacio ; Begona Ares Pensado ; Alfonso Castro Garcia ; Fernando Alonso Frech ; Mercedes Alvarez Lopez ; José Arbelo Gonzalez ; Joan Baiges Octavio ; Juan Andrés Burguera Herandez ; Matilde Calopa Garriga ; Dulce Campos Blanco ; Belén Castano Garcia ; Manuel Carballo Cordero ; José Chacon Pena ; Anna Espino Ibanez ; Aranzazu Gorospe Onisalde ; Santiago Gimenez-Roldan ; Pilar Granes Ibanez ; Jorge Hernandez Vara ; Ramon Ibanez Alonso ; Félix Javier Jimenez Jimenez ; Jerzy Krupinski ; Jaime Kulisevsky Bojarsky ; Inés Legarda Ramirez ; Elena Lezcano Garcia ; Juan Carlos Martinez-Castrillo ; Dolores Mateo Gonzalez ; Francesc Miquel Rodriguez ; Pablo Mir Rivera ; Elena Munoz Fargas ; José Obeso Inchausti ; Jesus Olivares Romero ; José Olive Plana ; Pilar Otermin Vallejo ; Berta Pascual Sedano ; Victor Perez De Colosia Rama ; Isabel Perez Lopez-Fraile ; Albert Planas Cornes ; Victor Puente Periz ; Maria Cruz Rodriguez Oroz ; Dolores Sevillano Garcia ; Pilar Solis Perez ; José Suarez Munoz ; Julia Vaamonde Gamo ; Caridad Valero Merino ; Francesc Valldeoriola Serra ; José Miguel Velazquez Perez ; Rosa Yanez Bana ; Ivana Zamarbide CapdeponEfficacy of Long-Term Continuous Subcutaneous Apomorphine Infusion in Advanced Parkinson's Disease with Motor Fluctuations : A Multicenter Study
001470 (2007) Carmine Vitale [Italie] ; Stefano Marconi [Italie] ; Luigi Di Maio [Italie] ; Giuseppe De Michele [Italie] ; Katia Longo [Italie] ; Vincenzo Bonavita [Italie] ; Paolo Barone [Italie]Short-Term Continuous Infusion of Apomorphine Hydrochloride for Treatment of Huntington's Chorea : A Double Blind, Randomized Cross-Over Trial
001B03 (2006) Angela Deutschl Nder [Allemagne] ; Friedrich Asmus [Allemagne] ; Elena Marelli [Allemagne] ; Thomas Klopstock [Allemagne] ; Thomas Gasser [Allemagne] ; Kai Botzel [Allemagne]Excellent response to apomorphine in parkinsonism with optic atrophy unresponsive to oral antiparkinsonian medication
001E71 (2005) Svenja Happe [Allemagne] ; Martin Sommer [Allemagne] ; Johannes Meller [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Walter Paulus [Allemagne]Dyskinesias due to intravenous apomorphine abuse in a patient without basal ganglia disorder
001E89 (2005) Regina Katzenschlager [Royaume-Uni, Autriche] ; Andrew Hughes [Australie] ; Andrew Evans [Royaume-Uni] ; Alice J. Manson [Royaume-Uni] ; Marion Hoffman [Australie] ; Lesley Swinn [Royaume-Uni] ; Hilary Watt [Royaume-Uni] ; Kailash Bhatia [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease : A prospective study using single-dose challenges
001F77 (2004) Lorenzo Priano [Italie] ; Gianni Albani [Italie] ; Andrea Brioschi [Italie] ; Sara Calderoni [Italie] ; Leonardo Lopiano [Italie] ; Mario Rizzone [Italie] ; Roberta Cavalli [Italie] ; Maria Rosa Gasco [Italie] ; Francesco Scaglione [Italie] ; Franco Fraschini [Italie] ; Bruno Bergamasco [Italie] ; Alessandro Mauro [Italie]Transdermal apomorphine permeation from microemulsions: A new treatment in Parkinson's Disease
002006 (2004) Jan C. M. Zijlmans [Royaume-Uni, Pays-Bas] ; Berengere Debilly [France] ; Olivier Rascol [France] ; Andrew Lees (neurologue) [Royaume-Uni] ; Franck Durif [France]Safety of entacapone and apomorphine coadministration in levodopa-treated Parkinson's disease patients: Pharmacokinetic and pharmacodynamic results of a multicenter, double-blind, placebo-controlled, cross-over study
002112 (2004) Svenja Happe [Allemagne] ; Tobias Tings [Allemagne] ; Kathrin Helmschmied [Allemagne] ; Karin Neubert [Allemagne] ; Wolfgang Wuttke [Allemagne] ; Walter Paulus [Allemagne] ; Claudia Trenkwalder [Allemagne]Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's disease
002199 (2004) Montse Alegret [Espagne] ; Francesc Valldeoriola [Espagne] ; Mjosé Marti [Espagne] ; Manuela Pilleri [Espagne] ; Carme Junque [Espagne] ; Jordi Rumia [Espagne] ; Eduardo Tolosa [Espagne]Comparative cognitive effects of Bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinson's disease
002666 (2002) Giulio Cicarelli [Italie] ; Maria Teresa Pellecchia [Italie] ; Giuseppe De Michele [Italie] ; Gilberto Pizzolato [Italie] ; Paolo Barone [Italie]Paradoxical response to apomorphine in a case of atypical parkinsonism
002708 (2002) Petr Kanovsky [République tchèque] ; Dagmar Kubova [République tchèque] ; Martin Bares [République tchèque] ; Hana Hortova [République tchèque] ; Hana Streitova [République tchèque] ; Ivan Rektor [République tchèque] ; Vladimir Znojil [République tchèque]Levodopa-induced dyskinesias and continuous subcutaneous infusions of apomorphine: Results of a two-year, prospective follow-up
002777 (2002) Guillermo Paradiso [Canada] ; Farooq Khan [Canada] ; Robert Chen [Canada]Effects of apomorphine on flexor reflex and periodic limb movement
002812 (2002) DA agonists: Non-Ergot derivatives: Apomorphine
002858 (2002) Alice J. Manson [Royaume-Uni] ; Kirsten Turner [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: Long-term follow-up study of 64 patients
002881 (2001) Han-Cheng Wang [Taïwan] ; YOLOUNG HSIEH [Taïwan]Treatment of neuroleptic malignant syndrome with subcutaneous apomorphine monotherapy

List of associated Author.i

Nombre de
documents
Descripteur
7Andrew Lees (neurologue)
3A. Cammarota
3C. Neef
3M. B. H. Youdim
3M. Merello
3Olivier Rascol
3R. Leiguarda
3T. Van Laar
3Werner Poewe
2A. Gross
2A. J. Hughes
2Alice J. Manson
2Christine Brefel-Courbon
2Claudia Trenkwalder
2F. Stocchi
2Giuseppe De Michele
2J. Balej
2J. G. Nutt
2J. Hildebrand
2L. Schelosky
2M. Danhof
2M. Gassen
2Monique Galitzky
2O. Betti
2Paolo Barone
2Pierre Pollak
2R. A. C. Roos
2S. Przedborski
2S. T. Gancher
2Svenja Happe
2W. R. Woodward
2Walter Paulus
1A. Albanese
1A. B. Naini
1A. Liard
1A. Muratorio
1A. Schrag
1A. W. F. Rutgers
1Alan R. Crossman
1Albert Planas Cornes
1Alberto Albanese
1Alessandro Mauro
1Alfonso Castro Garcia
1Amy Todd
1Andrea Brioschi
1Andrew Evans
1Andrew Hughes
1Angel Sesar Ignacio
1Angela Deutschl Nder
1Angélique Gerdelat-Mas
1Anna Espino Ibanez
1Anne-Marie Bonnet
1Aranzazu Gorospe Onisalde
1B. Kleedorfer
1B. Van Hilten
1Begona Ares Pensado
1Belén Castano Garcia
1Berengere Debilly
1Berta Pascual Sedano
1Brian Henry
1Bruno Bergamasco
1Bérengère Debilly
1C. Bouchard
1C. Farina
1C. Hunter
1C. Marquardt
1C. Raftopoulos
1C.-L. Gervason
1Caridad Valero Merino
1Carlo Colosimo
1Carme Junque
1Carmine Vitale
1Cherry Ann James
1Christine Brefel
1Claire Thalamas
1D. Frongillo
1D. L. Brown
1D. Le Bars
1D. M. Maraganore
1Dagmar Kubova
1David Peggs
1Dolores Mateo Gonzalez
1Dolores Sevillano Garcia
1Dulce Campos Blanco
1E. Broussolle
1E. Grünblatt
1E. Moro
1E. N. H. Jansen
1E. S. Molho
1Eduardo Tolosa
1Eldad Melamed
1Elena Lezcano Garcia
1Elena Marelli
1Elena Munoz Fargas
1Emmanuelle Bondon-Guitton
1Estelle Dellapina
1F. A. Delfino
1F. Lavenne
1F. Mauguiere
1F. Tison

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/FC03.fr.i -k "Apomorphine" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/FC03.fr.i  \
                -Sk "Apomorphine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    indexItem
   |index=    FC03.fr.i
   |clé=    Apomorphine
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024